Medical device, drug, and health care technology companies turn to Priya Kaulich to represent them in a wide range of corporate and health regulatory matters. Priya is passionate about advising mobile health start-ups in building out national telemedicine networks, and helping them comply with state and federal laws that impact telehealth services. Clients rely on her advice concerning corporate practice of medicine, scope of practice, professional licensure, and data privacy and security requirements, as well as health care fraud and abuse issues, such as anti-kickback and physician self-referral claims.
Priya is a contributing author of Epstein Becker Green’s Telemental Health Laws app, which provides a comprehensive survey of state telehealth laws, regulations, and policies for mental and behavioral health practitioners and stakeholders across all 50 states, the District of Columbia, and Puerto Rico.
Priya is also an active member of the Combination Products Coalition (CPC), a task force consisting of members of the drug, biologic, and medical device industry, whose aim is to work collaboratively with FDA on regulatory issues affecting combination products. Within the CPC, she serves as Epstein Becker Green’s representative for the Postmarket Safety Reporting and Bridging Working Groups. She enjoys working with and advocating for companies in the life sciences space to enact policy changes at the federal level.
While attending law school, Priya worked in the legal department of a large multinational medical device manufacturer, where she learned the importance of providing advice that is rooted in both law and practicality. She understands the skill it takes to present complex health regulatory concepts to lawyers and non-lawyers alike.